Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Spermotrend is a multi-ingredient dietary supplement developed by Catalysis Laboratories, specifically formulated to support male reproductive health and address male infertility. It contains a combination of antioxidants, minerals, and botanical extracts, including selenium, zinc, fructose, L-arginine, and *Pygeum africanum* extract. The product is designed to reduce oxidative stress in the male reproductive system, improve spermatogenesis parameters such as sperm concentration, motility, and morphology, and potentially alleviate symptoms associated with benign prostatic hyperplasia (BPH) and varicocele. Its mechanism involves providing essential precursors for nitric oxide production (L-arginine) and utilizing the antioxidant and anti-inflammatory properties of its components to protect sperm from oxidative damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Spermotrend.